Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 22, 2024Current Medical Research and Opinion

Management of hepatorenal syndrome and treatment-related adverse events

View Full Paper
Ask AI
Bookmark
Share

Authors

LPLorenzo PelusoUniversity of VeronaMSMarzia SaviCambridge University Hospitals NHS Foundation TrustGCGiacomo CoppaliniUniversité Libre de Bruxelles

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Peluso et al. (2024) studied this question.

synapsesocial.com/papers/68e68e94b6db6435876163c8https://doi.org/10.1080/03007995.2024.2358242
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1NAFLD as a continuum: from obesity to metabolic syndrome and diabetes2020 · 658 citations
  2. 2Serum Albumin in Health and Disease: Esterase, Antioxidant, Transporting and Signaling Properties2021 · 399 citations
  3. 3The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 20172020 · 1,753 citations
  4. 4Hepatorenal syndrome: Current concepts and future perspectives2023 · 34 citations
  5. 5Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute‐on‐chronic liver failure2022 · 74 citations